153 related articles for article (PubMed ID: 9427374)
1. Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo.
Aboody-Guterman KS; Pechan PA; Rainov NG; Sena-Esteves M; Jacobs A; Snyder EY; Wild P; Schraner E; Tobler K; Breakefield XO; Fraefel C
Neuroreport; 1997 Dec; 8(17):3801-8. PubMed ID: 9427374
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
3. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
[TBL] [Abstract][Full Text] [Related]
4. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
[TBL] [Abstract][Full Text] [Related]
5. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
[TBL] [Abstract][Full Text] [Related]
6. A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma.
Rainov NG; Sena-Esteves M; Fraefel C; Dobberstein KU; Chiocca EA; Breakefield XO
Adv Exp Med Biol; 1998; 451():393-403. PubMed ID: 10026902
[TBL] [Abstract][Full Text] [Related]
7. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
Herrlinger U; Jacobs A; Quinones A; Woiciechowsky C; Sena-Esteves M; Rainov NG; Fraefel C; Breakefield XO
Hum Gene Ther; 2000 Jul; 11(10):1429-38. PubMed ID: 10910140
[TBL] [Abstract][Full Text] [Related]
8. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.
Shah K; Tang Y; Breakefield X; Weissleder R
Oncogene; 2003 Oct; 22(44):6865-72. PubMed ID: 14534533
[TBL] [Abstract][Full Text] [Related]
9. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
10. Detection of brain tumor invasion and micrometastasis in vivo by expression of enhanced green fluorescent protein.
MacDonald TJ; Tabrizi P; Shimada H; Zlokovic BV; Laug WE
Neurosurgery; 1998 Dec; 43(6):1437-42; discussion 1442-3. PubMed ID: 9848858
[TBL] [Abstract][Full Text] [Related]
11. Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector.
Kummer C; Winkeler A; Dittmar C; Bauer B; Rueger MA; Rueckriem B; Heneka MT; Vollmar S; Wienhard K; Fraefel C; Heiss WD; Jacobs AH
Mol Imaging; 2007; 6(3):181-92. PubMed ID: 17532884
[TBL] [Abstract][Full Text] [Related]
12. A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors.
Pechan PA; Fotaki M; Thompson RL; Dunn R; Chase M; Chiocca EA; Breakefield XO
Hum Gene Ther; 1996 Oct; 7(16):2003-13. PubMed ID: 8930661
[TBL] [Abstract][Full Text] [Related]
13. Modified herpes simplex virus delivery of enhanced GFP into the central nervous system.
Sandler VM; Wang S; Angelo K; Lo HG; Breakefield XO; Clapham DE
J Neurosci Methods; 2002 Dec; 121(2):211-9. PubMed ID: 12468010
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors.
Boviatsis EJ; Chase M; Wei MX; Tamiya T; Hurford RK; Kowall NW; Tepper RI; Breakefield XO; Chiocca EA
Hum Gene Ther; 1994 Feb; 5(2):183-91. PubMed ID: 8186298
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 1 amplicon vector-mediated gene transfer to muscle.
Wang Y; Mukherjee S; Fraefel C; Breakefield XO; Allen PD
Hum Gene Ther; 2002 Jan; 13(2):261-73. PubMed ID: 11812282
[TBL] [Abstract][Full Text] [Related]
16. Imaging herpes simplex virus type 1 amplicon vector-mediated gene expression in human glioma spheroids.
Kaestle C; Winkeler A; Richter R; Sauer H; Hescheler J; Fraefel C; Wartenberg M; Jacobs AH
Mol Imaging; 2011 Jun; 10(3):197-205. PubMed ID: 21443839
[TBL] [Abstract][Full Text] [Related]
17. Targeting human glioma cells using HSV-1 amplicon peptide display vector.
Ho IA; Miao L; Sia KC; Wang GY; Hui KM; Lam PY
Gene Ther; 2010 Feb; 17(2):250-60. PubMed ID: 19812609
[TBL] [Abstract][Full Text] [Related]
18. Efficient and non-toxic gene transfer to cardiomyocytes using novel generation amplicon vectors derived from HSV-1.
Ferrera R; Cuchet D; Zaupa C; Revol-Guyot V; Ovize M; Epstein AL
J Mol Cell Cardiol; 2005 Jan; 38(1):219-23. PubMed ID: 15623439
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a cellular vaccination approach consisting of crawling dendritic cells (CDCs) transduced with HSV-1-Deltapac vectors.
Nuñez R; Fraefel C; Suter M; Nuñez-Liman A; Liou HC; Ackerman M
Immunol Res; 2004; 30(1):105-24. PubMed ID: 15258314
[TBL] [Abstract][Full Text] [Related]
20. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.
Herrlinger U; Woiciechowski C; Sena-Esteves M; Aboody KS; Jacobs AH; Rainov NG; Snyder EY; Breakefield XO
Mol Ther; 2000 Apr; 1(4):347-57. PubMed ID: 10933953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
